Wall Street analysts expect Tivity Health, Inc. (NASDAQ: TVTY) to report $ 126.05 million in sales for the current quarter, Zacks reports. Four analysts provided revenue estimates for Tivity Health. The lowest sales estimate is $ 124.53 million and the highest is $ 128.10 million. Tivity Health reported sales of $ 100.62 million in the same quarter last year, suggesting a positive growth rate of 25.3% year-over-year. The company is expected to release its next quarterly results on Wednesday, February 23.
Zacks says analysts expect Tivity Health to report annual revenue of $ 480.47 million for the current fiscal year, with estimates ranging from $ 478.98 million to $ 482.50 million of dollars. For next year, analysts predict the company will post sales of $ 530.78 million, with estimates ranging from $ 504.57 million to $ 555.70 million. Zacks’ sales calculations are an average based on a survey of analysts who follow Tivity Health.
Tivity Health (NASDAQ: TVTY) last released its quarterly results on Tuesday, November 2. The company reported earnings per share (EPS) of $ 0.42 for the quarter, beating Thomson Reuters’ consensus estimate of $ 0.36 of $ 0.06. Tivity Health reported a return on equity of 163.79% and a net margin of 26.07%. During the same period of the previous year, the company posted earnings per share of $ 0.72.
Several stock analysts weighed on TVTY shares. Truist Securities lowered its price target on Tivity Health from $ 28.00 to $ 25.00 and set a “custody” rating for the company in a report released on Monday, August 23. Truist lowered its price target on Tivity Health from $ 28.00 to $ 25.00 and set a “conservation” rating for the company in a report released on Monday, August 23. Credit Suisse Group raised its price target on Tivity Health from $ 21.00 to $ 25 and gave the company an “underperformance” rating in a report released on Tuesday, November 9. Finally, Barrington Research raised its price target on Tivity Health from $ 31.00 to $ 33.00 and gave the company an “outperformance” rating in a report released on Wednesday, November 3. One research analyst rated the stock with a sell rating, four issued a conservation rating, and two assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $ 27.86.
Institutional investors recently bought and sold shares in the company. AQR Capital Management LLC increased its stake in Tivity Health shares by 42.3% during the 2nd quarter. AQR Capital Management LLC now owns 61,526 shares of the company valued at $ 1,619,000 after purchasing an additional 18,282 shares in the last quarter. Caxton Associates LP acquired a new position in shares of Tivity Health during the second quarter valued at $ 439,000. The Alaska State Department of Revenue increased its stake in Tivity Health shares by 22.9% during the 3rd quarter. The Alaska State Department of Revenue now owns 32,231 shares of the company valued at $ 743,000 after purchasing an additional 6,000 shares in the last quarter. Putnam Investments LLC acquired a new position in Tivity Health in the second quarter valued at approximately $ 4,389,000. Finally, BNP Paribas Arbitrage SA increased its stake in Tivity Health by 87.7% in the second quarter. BNP Paribas Arbitrage SA now owns 32,610 shares of the company valued at $ 858,000 after purchasing an additional 15,234 shares during the last quarter. 88.24% of the shares are held by institutional investors.
TVTY opened at $ 24.27 on Tuesday. The company has a market cap of $ 1.21 billion, a P / E ratio of 10.28, a PEG ratio of 1.51 and a beta of 2.39. The company has a debt to equity ratio of 2.71, a current ratio of 2.47 and a quick ratio of 2.47. The company has a fifty-day moving average price of $ 25.40. Tivity Health has a one-year low at $ 17.73 and a one-year high at $ 29.18.
About Tivity Santé
Tivity Health, Inc provides fitness, nutrition and social connection solutions. It operates through two segments: Health and Nutrition. The Healthcare segment includes SilverSneakers senior fitness, Prime Fitness and WholeHealth Living. The Nutrition segment provides weight management products and services and includes Nutrisystem and South Beach Diet.
Read more: What are no-load funds?
Get a Free Copy of Zacks’ Research Report on Tivity Health (TVTY)
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team before publication. Please send any questions or comments about this story to [email protected]
Should you invest $ 1,000 in Tivity Health now?
Before you consider Tivity Health, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts quietly whisper to their clients to buy now before the broader market takes hold … and Tivity Health was not on the list.
While Tivity Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better bets.
See the 5 actions here